Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,681 | -24,033 | -16,446 | -8,063 | -22,105 |
| Depreciation Amortization | 338 | 253 | 166 | 83 | 283 |
| Accounts receivable | 1,660 | 1,660 | 660 | 1,660 | -1,660 |
| Accounts payable and accrued liabilities | -469 | 394 | -787 | 484 | 1,297 |
| Other Working Capital | 18,223 | 9,520 | -1,033 | -726 | -2,515 |
| Other Operating Activity | 1,770 | 377 | 1,741 | -1,252 | 429 |
| Operating Cash Flow | $-8,159 | $-11,829 | $-15,699 | $-7,814 | $-24,271 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -174 | -53 | -27 | -120 | -1,677 |
| Investing Cash Flow | $-174 | $-53 | $-27 | $-120 | $-1,677 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,993 | 4,975 | 8 | 8 | 25,089 |
| Financing Cash Flow | $4,993 | $4,975 | $8 | $8 | $25,089 |
| Beginning Cash Position | 24,237 | 24,237 | 24,237 | 24,237 | 25,096 |
| End Cash Position | 20,897 | 17,330 | 8,519 | 16,311 | 24,237 |
| Net Cash Flow | $-3,340 | $-6,907 | $-15,718 | $-7,926 | $-859 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,159 | -11,829 | -15,699 | -7,814 | -24,271 |
| Capital Expenditure | -174 | -53 | -27 | -120 | -1,677 |
| Free Cash Flow | -8,333 | -11,882 | -15,726 | -7,934 | -25,948 |